Lyman, G. H., Dale, D. C., Culakova, E., Poniewierski, M. S., Wolff, D. A., Kuderer, N. M., & Crawford, J. (2010). Overall survival in randomized controlled trials of chemotherapy (CT) with or without GCSF support: A systematic review. In Journal of Clinical Oncology (Vol. 28, pp. 9141–9141). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2010.28.15_suppl.9141

Lyman, G. H., D. C. Dale, E. Culakova, M. S. Poniewierski, D. A. Wolff, N. M. Kuderer, and J. Crawford. “Overall survival in randomized controlled trials of chemotherapy (CT) with or without GCSF support: A systematic review.” In Journal of Clinical Oncology, 28:9141–9141. American Society of Clinical Oncology (ASCO), 2010. https://doi.org/10.1200/jco.2010.28.15_suppl.9141.

Lyman GH, Dale DC, Culakova E, Poniewierski MS, Wolff DA, Kuderer NM, et al. Overall survival in randomized controlled trials of chemotherapy (CT) with or without GCSF support: A systematic review. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. 9141–9141.

Lyman, G. H., et al. “Overall survival in randomized controlled trials of chemotherapy (CT) with or without GCSF support: A systematic review.” Journal of Clinical Oncology, vol. 28, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2010, pp. 9141–9141. Crossref, doi:10.1200/jco.2010.28.15_suppl.9141.

Lyman GH, Dale DC, Culakova E, Poniewierski MS, Wolff DA, Kuderer NM, Crawford J. Overall survival in randomized controlled trials of chemotherapy (CT) with or without GCSF support: A systematic review. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. 9141–9141.